The THOR IDE Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 155 participants.
Also called NCT05916950
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 155 participants
- Registry
-
NCT05916950
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05916950. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-29 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The THOR IDE Study
- Acronym
- THOR
- Condition
- Peripheral Artery Disease
- Condition
- Peripheral Artery Stenosis
- Condition
- Peripheral Artery Calcification
- Condition
- PAD
- Intervention (Device)
- Thor laser atherectomy
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Collaborator
- NAMSA
- Collaborator
- Syntropic
Record details
- Record id
cardio:ct-nct05916950- Content hash
023a7f5b3d50f226724998a4767e6f1ef7d7b944f7418492f07047db11c7a29a